Cargando…

Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study

BACKGROUND: Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-even...

Descripción completa

Detalles Bibliográficos
Autores principales: Marateb, Hamid Reza, von Cube, Maja, Sami, Ramin, Haghjooy Javanmard, Shaghayegh, Mansourian, Marjan, Amra, Babak, Soltaninejad, Forogh, Mortazavi, Mojgan, Adibi, Peyman, Khademi, Nilufar, Sadat Hosseini, Nastaran, Toghyani, Arash, Hassannejad, Razieh, Mañanas, Miquel Angel, Binder, Harald, Wolkewitz, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278186/
https://www.ncbi.nlm.nih.gov/pubmed/34261439
http://dx.doi.org/10.1186/s12874-021-01340-8
_version_ 1783722215458471936
author Marateb, Hamid Reza
von Cube, Maja
Sami, Ramin
Haghjooy Javanmard, Shaghayegh
Mansourian, Marjan
Amra, Babak
Soltaninejad, Forogh
Mortazavi, Mojgan
Adibi, Peyman
Khademi, Nilufar
Sadat Hosseini, Nastaran
Toghyani, Arash
Hassannejad, Razieh
Mañanas, Miquel Angel
Binder, Harald
Wolkewitz, Martin
author_facet Marateb, Hamid Reza
von Cube, Maja
Sami, Ramin
Haghjooy Javanmard, Shaghayegh
Mansourian, Marjan
Amra, Babak
Soltaninejad, Forogh
Mortazavi, Mojgan
Adibi, Peyman
Khademi, Nilufar
Sadat Hosseini, Nastaran
Toghyani, Arash
Hassannejad, Razieh
Mañanas, Miquel Angel
Binder, Harald
Wolkewitz, Martin
author_sort Marateb, Hamid Reza
collection PubMed
description BACKGROUND: Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. METHODS: We used the hospital-based open Khorshid COVID Cohort (KCC) study with 630 COVID-19 patients from Isfahan, Iran. Competing risk methods are used to develop a death risk chart based on the following variables, which can simply be measured at hospital admission: sex, age, hypertension, oxygen saturation, and Charlson Comorbidity Index. The area under the receiver operator curve was used to assess accuracy concerning discrimination between patients discharged alive and dead. RESULTS: Cause-specific hazard regression models show that these baseline variables are associated with both death, and discharge hazards. The risk chart reflects the combined results of the two cause-specific hazard regression models. The proposed risk assessment method had a very good accuracy (AUC = 0.872 [CI 95%: 0.835–0.910]). CONCLUSIONS: This study aims to improve and validate a personalized mortality risk calculator based on hospitalized COVID-19 patients. The risk assessment of patient mortality provides physicians with additional guidance for making tough decisions.
format Online
Article
Text
id pubmed-8278186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82781862021-07-14 Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study Marateb, Hamid Reza von Cube, Maja Sami, Ramin Haghjooy Javanmard, Shaghayegh Mansourian, Marjan Amra, Babak Soltaninejad, Forogh Mortazavi, Mojgan Adibi, Peyman Khademi, Nilufar Sadat Hosseini, Nastaran Toghyani, Arash Hassannejad, Razieh Mañanas, Miquel Angel Binder, Harald Wolkewitz, Martin BMC Med Res Methodol Research Article BACKGROUND: Already at hospital admission, clinicians require simple tools to identify hospitalized COVID-19 patients at high risk of mortality. Such tools can significantly improve resource allocation and patient management within hospitals. From the statistical point of view, extended time-to-event models are required to account for competing risks (discharge from hospital) and censoring so that active cases can also contribute to the analysis. METHODS: We used the hospital-based open Khorshid COVID Cohort (KCC) study with 630 COVID-19 patients from Isfahan, Iran. Competing risk methods are used to develop a death risk chart based on the following variables, which can simply be measured at hospital admission: sex, age, hypertension, oxygen saturation, and Charlson Comorbidity Index. The area under the receiver operator curve was used to assess accuracy concerning discrimination between patients discharged alive and dead. RESULTS: Cause-specific hazard regression models show that these baseline variables are associated with both death, and discharge hazards. The risk chart reflects the combined results of the two cause-specific hazard regression models. The proposed risk assessment method had a very good accuracy (AUC = 0.872 [CI 95%: 0.835–0.910]). CONCLUSIONS: This study aims to improve and validate a personalized mortality risk calculator based on hospitalized COVID-19 patients. The risk assessment of patient mortality provides physicians with additional guidance for making tough decisions. BioMed Central 2021-07-14 /pmc/articles/PMC8278186/ /pubmed/34261439 http://dx.doi.org/10.1186/s12874-021-01340-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Marateb, Hamid Reza
von Cube, Maja
Sami, Ramin
Haghjooy Javanmard, Shaghayegh
Mansourian, Marjan
Amra, Babak
Soltaninejad, Forogh
Mortazavi, Mojgan
Adibi, Peyman
Khademi, Nilufar
Sadat Hosseini, Nastaran
Toghyani, Arash
Hassannejad, Razieh
Mañanas, Miquel Angel
Binder, Harald
Wolkewitz, Martin
Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
title Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
title_full Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
title_fullStr Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
title_full_unstemmed Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
title_short Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study
title_sort absolute mortality risk assessment of covid-19 patients: the khorshid covid cohort (kcc) study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278186/
https://www.ncbi.nlm.nih.gov/pubmed/34261439
http://dx.doi.org/10.1186/s12874-021-01340-8
work_keys_str_mv AT maratebhamidreza absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT voncubemaja absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT samiramin absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT haghjooyjavanmardshaghayegh absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT mansourianmarjan absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT amrababak absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT soltaninejadforogh absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT mortazavimojgan absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT adibipeyman absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT khademinilufar absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT sadathosseininastaran absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT toghyaniarash absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT hassannejadrazieh absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT mananasmiquelangel absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT binderharald absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy
AT wolkewitzmartin absolutemortalityriskassessmentofcovid19patientsthekhorshidcovidcohortkccstudy